Westlake Chemical Partners LP is a chemicals business based in the US. Westlake Chemical Partners shares (WLKP) are listed on the NYSE and all prices are listed in US Dollars.
How to buy shares in Westlake Chemical Partners
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – WLKP – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Westlake Chemical Partners stock price (NYSE: WLKP)Use our graph to track the performance of WLKP stocks over time.
Westlake Chemical Partners shares at a glance
|Latest market close||$26.47|
|52-week range||$21.61 - $27.40|
|50-day moving average||$24.96|
|200-day moving average||$25.94|
|Wall St. target price||$28.14|
|Dividend yield||$1.886 (7.21%)|
|Earnings per share (TTM)||$1.93|
Buy Westlake Chemical Partners shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Westlake Chemical Partners stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Westlake Chemical Partners price performance over time
|1 week (2022-01-19)||-1.05%|
|1 month (2021-12-23)||6.48%|
|3 months (2021-10-26)||2.28%|
|6 months (2021-07-26)||-2.04%|
|1 year (2021-01-26)||11.50%|
|2 years (2020-01-24)||10.34%|
|3 years (2019-01-25)||16.61%|
|5 years (2017-01-26)||7.82%|
Is Westlake Chemical Partners stock undervalued or overvalued?
Valuing Westlake Chemical Partners stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Westlake Chemical Partners's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Westlake Chemical Partners's P/E ratio
Westlake Chemical Partners's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 14x. In other words, Westlake Chemical Partners shares trade at around 14x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Westlake Chemical Partners's PEG ratio
Westlake Chemical Partners's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.23. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Westlake Chemical Partners's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Westlake Chemical Partners's EBITDA
Westlake Chemical Partners's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $455.7 million.
The EBITDA is a measure of a Westlake Chemical Partners's overall financial performance and is widely used to measure a its profitability.
Westlake Chemical Partners financials
|Revenue TTM||$1.1 billion|
|Operating margin TTM||30.75%|
|Gross profit TTM||$378.9 million|
|Return on assets TTM||15.84%|
|Return on equity TTM||36.68%|
|Market capitalisation||$932.1 million|
TTM: trailing 12 months
Westlake Chemical Partners share dividends
Dividend payout ratio: 97.7% of net profits
Recently Westlake Chemical Partners has paid out, on average, around 97.7% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 7.21% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Westlake Chemical Partners shareholders could enjoy a 7.21% return on their shares, in the form of dividend payments. In Westlake Chemical Partners's case, that would currently equate to about $1.886 per share.
Westlake Chemical Partners's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Westlake Chemical Partners's most recent dividend payout was on 28 November 2021. The latest dividend was paid out to all shareholders who bought their shares by 9 November 2021 (the "ex-dividend date").
Westlake Chemical Partners share price volatility
Over the last 12 months, Westlake Chemical Partners's shares have ranged in value from as little as $21.6149 up to $27.4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Westlake Chemical Partners's is 1.149. This would suggest that Westlake Chemical Partners's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Westlake Chemical Partners overview
Westlake Chemical Partners LP acquires, develops, and operates ethylene production facilities and related assets in the United States. The company's ethylene production facilities primarily convert ethane into ethylene. It also sells ethylene co-products, including propylene, crude butadiene, pyrolysis gasoline, and hydrogen directly to third parties on a spot or contract basis. Westlake Chemical Partners GP LLC serves as the general partner of the company. The company was founded in 2014 and is headquartered in Houston, Texas. .
Westlake Chemical Partners in the news
Westlake Chemical Partners LP Announces Fourth Quarter 2021 Distribution
Can Westlake (WLK) Keep the Earnings Surprise Streak Alive?
Best Growth Stocks to Buy for January 24th
Frequently asked questionsWhat percentage of Westlake Chemical Partners is owned by insiders or institutions?
Currently 44.941% of Westlake Chemical Partners shares are held by insiders and 32.189% by institutions. When does the fiscal year end for Westlake Chemical Partners?
Westlake Chemical Partners's fiscal year ends in December. Where is Westlake Chemical Partners based?
Westlake Chemical Partners's address is: 2801 Post Oak Boulevard, Houston, TX, United States, 77056 What is Westlake Chemical Partners's ISIN number?
Westlake Chemical Partners's international securities identification number is: US9604171036 What is Westlake Chemical Partners's CUSIP number?
Westlake Chemical Partners's Committee on Uniform Securities Identification Procedures number is: 960417103
More guides on Finder
Dogecoin jumps 10% on word you can use it to buy Tesla merch
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
Thursday’s top U.S. stocks: Taiwan Semiconductor Manufacturing Company Ltd. (TSM ↑8.4%), Lam Research Corporation (LRCX ↑6.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
How to buy Nexalin Technology (NXL) stock when it goes public
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
Ask an Expert